Market Place
Sourcing Support
Acousia To Present ACOU085 Phase 2 Study At Upcoming Conferences
12 Aug 2024 //
PR NEWSWIRE
Acousia attracts investor on its path to make hearing loss a treatable disease
09 Jan 2024 //
PR NEWSWIRE
Acousia to present key learnings and data from lead development programs
23 Aug 2023 //
PR NEWSWIRE
Hearing loss company Acousia completes Phase 1 study with its small molecule
12 Dec 2022 //
PRNEWSWIRE
Hearing loss company Acousia completes clinical PhI study with small molecule
12 Dec 2022 //
PRNEWSWIRE
Acousia to present data for lead candidates ACOU085 & ACOU082 at ARO Meeting
24 Nov 2022 //
PRNEWSWIRE
Acousia to present first-in-class hearing loss treatment program with ACOU085
11 May 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.